NF2 mutation status and tumor mutational burden correlate with immune cell infiltration in meningiomas
- 31 December 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cancer Immunology, Immunotherapy
- Vol. 70 (1), 169-176
- https://doi.org/10.1007/s00262-020-02671-z
Abstract
Background The tumor microenvironment is an emerging biomarker of underlying genomic heterogeneity and response to immunotherapy-based treatment regimens in solid malignancies. How tumor mutational burden influences the density, distribution, and presence of a localized immune response in meningiomas is unknown. Methods Representative hematoxylin and eosin slides were reviewed at 40X to assess for the density of inflammatory cells. Lymphocytes and macrophages were quantified in the following ordinal manner: 0 = not present, 1 = 1-25 cells present, and 2 = greater than 26 cells present. Immune cell infiltrate grade was scored for both scattered and aggregated distributions. Next generation targeted sequencing was performed on all meningiomas included in this study. Results One hundred and forty-five meningiomas were evaluated in this study. Lymphocytes were observed in both scattered (95.9%) and aggregated (21.4%) distributions. A total of 115 (79.3%) meningiomas had 1-25 scattered lymphocytes, and 24 (16.6%) had > 25 scattered lymphocytes, and 6 (4.1%) had no scattered lymphocytes. Twenty (13.8%) meningiomas had 1-25 aggregated lymphocytes. Eleven (7.6%) had > 25 aggregated lymphocytes and 114 (78.6%) had no aggregated lymphocytes. Six (4.1%) meningiomas had 1-25 aggregated macrophages, 5 (3.4%) had > 25 aggregated macrophages, and 134 (92.4%) had no aggregated macrophages. Density of aggregated lymphocytes and aggregated macrophages were associated with higher tumor grade, P = 0.0071 and P = 0.0068, respectively. Scattered lymphocyte density was not associated with meningioma grade. The presence of scattered lymphocytes was associated with increased tumor mutational burden. Meningiomas that did not have scattered lymphocytes had a mean number of single mutations of 2.3 +/- 2.9, compared with meningiomas that had scattered lymphocytes, 6.9 +/- 20.3,P = 0.03.NF2mutations were identified in 59 (40.7%) meningiomas and were associated with increased density of scattered lymphocytes.NF2mutations were seen in 0 (0%) meningiomas that did not have scattered lymphocytes, 46 (40.0%) meningiomas that had 1-25 scattered lymphocytes, and 13 (54.2%) meningiomas that had > 25 scattered lymphocytes,P = 0.046. Conclusions Our findings suggest that distribution of immune cell infiltration in meningiomas is associated with tumor mutational burden.NF2mutational status was associated with an increasing density of scattered lymphocytes. As the role of immunotherapy in meningiomas continues to be elucidated with clinical trials that are currently underway, these results may serve as a novel biomarker of tumor mutational burden in meningiomas.This publication has 43 references indexed in Scilit:
- Surgery for convexity meningioma: Simpson Grade I resection as the goalJournal of Neurosurgery, 2012
- Gene Expression Profile Correlates with T-Cell Infiltration and Relative Survival in Glioblastoma Patients Vaccinated with Dendritic Cell ImmunotherapyClinical Cancer Research, 2011
- Immunotherapy Approaches for Malignant Glioma From 2007 to 2009Current Neurology and Neuroscience Reports, 2010
- The microglial/macrophagic response at the tumour–brain border of invasive meningiomasNeuropathology and Applied Neurobiology, 2009
- Hitting a moving target: evolution of a treatment paradigm for atypical meningiomas amid changing diagnostic criteriaNeurosurgical Focus, 2008
- Recurrence and Outcome in Skull Base Meningiomas: Do They Differ from Other Intracranial Meningiomas?Journal of Neurological Surgery Part B: Skull Base, 2007
- Interinstitutional variance of postoperative radiotherapy and follow up for meningiomas in Germany: impact of changes of the WHO classificationJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical casesJournal of Neurosurgery, 1997
- Immunohistological investigation of mononuclear cell infiltrates in meningiomasActa Neuropathologica, 1989
- Immunocytochemical study of the cellular immune response in meningiomas.Journal of Clinical Pathology, 1988